ISRACANN BIOSCIENCES INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.015 CAD | -.--% |
|
-.--% | -.--% |
| Jan. 23 | Isracann Biosciences Inc. Announces Management Changes | CI |
| Jan. 23 | Isracann Biosciences Inc. Announces Resignation of Yana Popova as CFO | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Companyâs operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 1.93M | |
| +39.54% | 6.12B | |
| -16.47% | 4.44B | |
| -10.16% | 3.14B | |
| -0.71% | 3.03B | |
| -1.06% | 2.57B | |
| +40.09% | 1.87B | |
| -0.76% | 1.63B | |
| -11.19% | 1.62B | |
| -12.74% | 1.53B |
- Stock Market
- Equities
- IPOT Stock
- News Isracann Biosciences Inc.
- Isracann Biosciences : Names New CEO
